PVPaola Andrea Vargas

Paola Andrea Vargas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paola Andrea Vargas has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Postoperative outcomes in living donor liver transplant vs. deceased donor liver transplant in patients with metabolic dysfunction-associated steatohepatitis: a UNOS database analysis

    by Maurus P. Steigmeier, Todd J. Robinson, Paola A. Vargas, Abdulghani Abou Koura, Shawn J. Pelletier, Jose Oberholzer, Nicolas Goldaracena

    Original Article Postoperative outcomes in living donor liver transplant vs. deceased donor liver transplant in patients with metabolic dysfunction-associated steatohepatitis: a UNOS database analysis Maurus P. Steigmeier, Todd J. Robinson, Paola A. Vargas, Abdulghani Abou Koura, Shawn J. Pelletier, Jose Oberholzer, Nicolas Goldaracena

  • Open Access

    Are we on track to increase organ utilization? An analysis of machine perfusion preservation for liver transplantation in the United States

    by Todd Robinson, Paola A. Vargas, Renana Yemini, Nicolas Goldaracena, Shawn Pelletier

    Background: Efforts to improve the quality of marginal grafts for transplantation are essential. Machine perfusion preservation appears as a promising solution.Methods: The United Network for Organ Sharing (UNOS) database was queried for deceased liver donor records between 2016 and 2022. The primary outcome of interest was the organ nonutilization rate. Long‐term graft and patient survival among extended criteria donors (ECDs) were also analyzed.Results: During the study period, out of 54 578 liver grafts recovered for transplant, 5085 (9.3%) were nonutilized. Multivariable analysis identified normothermic machine perfusion (NMP) preservation as the only predictor associated with a reduction in graft nonutilization (OR = 0.12; 95% CI = 0.06–0.023, p < 0.001). Further analysis of ECD grafts that were transplanted revealed comparable 1‐,2‐ and 3‐years graft survival (89%/88%/82% vs. 90%/85%/81%, p = 0.60), and patient survival (92%/91%/84% vs. 92%/88%/84%, p = 0.65) between grafts that underwent MP vs. those who did not, respectively.Conclusions: Liver nonutilization rates in the United States are at an all‐time high. Available data, most likely including cases from clinical trials, showed that NMP reduced the odds of organ nonutilization by 12% among the entire deceased donor pool and by 16% among grafts from ECD. Collective efforts and further evidence reflecting day‐to‐day clinical practice are needed to fully reach the potential of MP for liver transplant.


  • Hepatic artery infusion pump for unresectable colorectal liver metastases before living donor liver transplant: Oncological friend or technical foe?

    by Nicolas Goldaracena, Alice Zhu, Paola A. Vargas, Paul Karanicolas, Zachary Henry, Blayne Amir Sayed, Mark Cattral, Luckshi Rajendran, Anand Ghanekar, Gonzalo Sapisochin

    An abstract is unavailable. This article is available as a PDF only.


  • Open Access

    Alternatives to left lateral segment for pediatric liver transplantation, or required surgeon toolkit?

    by Paola A. Vargas, Nicolas Goldaracena

    Alternatives to left lateral segment for pediatric liver transplantation, or required surgeon toolkit?


  • Open Access

    Pre-operative assessment of living liver donors’ liver anatomy and volumes

    by Nicolas Goldaracena, Paola A. Vargas, Lucas McCormack

    Decades of experience supports LDLT as a favorable strategy to reduce waitlist mortality. The multiple regenerative pathways of hepatocytes and other hepatic cells justify the rationale behind it. Nonetheless, living liver donation is still underused and its broader implementation is challenging, mostly due to variability in practices leading to concerns related to donor safety. A non-systematic literature search was conducted for peer-reviewed original articles related to pre-operative evaluation of living liver donor candidates. Eligible studies were synthesized upon consensus for discussion in this up-to-date review. Review of the literature demonstrate that the importance of preoperative assessment of vascular, biliary and liver volume to ensure donor safety and adequate surgical planning for graft procurement is widely recognized. Moreover, data indicates that anatomic variants in vascular and biliary systems in healthy donors are common, present in up to 50% of the population. Therefore, comprehensive mapping and visualizations of each component is needed. Different imaging modalities are reported across practices and are discussed in detail. Lastly, assessment of liver volume must take into account several technical and donor factors that increase the chances of errors in volume estimation, which occurs in up to 10% of the cases. Experience suggests that maximizing donor safety and lessening their risks is a result of integrated experience between hepatobiliary and transplant surgery, along with multidisciplinary efforts in performing a comprehensive pre-operative donor assessment. Although technical advances have increased the accuracy of volume estimation, over- or under-estimation remains a challenge that needs further attention.


  • Open Access

    Simultaneous split liver/kidney transplantation: A national and single center experience report

    by Radhika Rastogi, Paola A. Vargas, Jose Oberholzer, Shawn Pelletier, Nicolas Goldaracena

    Background: End‐stage liver disease (ESLD) and end‐stage renal disease (ESRD) are prevalent diseases for which the definitive treatment is transplantation. With limited organ supply, strategies to maximize organ availability has led to increasing rates of split liver transplantations for ESLD patients. Therefore, simultaneous split liver and kidney transplantations (SSLK) for patients with ESLD and ESRD could represent a treatment option for comorbid patients. However, current practice and outcomes after SSLK are unknown.Methods: We aim to report national trends and our experience with patients undergoing SSLK. We performed a retrospective review of the United Network for Organ Sharing (UNOS) Standard Transplant Analysis and Research file from January 2011–April 2022. Descriptive analysis of preoperative characteristics, postoperative outcomes and actuarial graft and patient survivals are reported.Results: National review of the UNOS transplant registry from 2011–2021 of adult patients undergoing initial transplantation via SSLK demonstrates that this procedure remains uncommon, with only 76 such cases captured in that time. Nevertheless, survival rates at 1, 3, and 5 years remains robust, at 94%, 92%, and 90% for patients overall, 90%, 88%, 88%, for the liver graft, and 93%, 91%, 88% for the kidney graft, respectively. Review of a single center experience with three such patients from 2019–2021 has shown a safe, enduring transplant option with no graft complications seen.Conclusions: SSLK is both safe and a feasible option to optimize organ supply while allowing recipients to receive quality liver and kidney grafts and should be considered more often by transplant centers going forward.


  • Open Access

    Survival after LDLT in recipients ≥70 years old in the United States. An OPTN/UNOS liver transplant registry analysis

    by Todd Robinson, Paola A. Vargas, Jose Oberholzer, Shawn Pelletier, Nicolas Goldaracena

    Background: Living donor liver transplantation (LDLT) in the elderly population is currently not well studied. There are single‐center studies indicating that patient age should not be a barrier to LDLT, with similar outcomes compared to younger recipients.Methods: Using UNOS/STAR data from 2010 to 2022 we retrospectively analyzed patients ≥70 years old receiving a living donor graft (LDLT ≥70y group) versus a deceased donor graft (DDLT ≥70y group). In addition, we compared recipients ≥70 years old undergoing LDLT versus patients 18–69 years old also undergoing LDLT. Donor and recipient baseline characteristics, as well as postoperative outcomes including graft and patient survival were analyzed and compared between groups.Results: Recipients in the LDLT ≥70y group showed less disease burden and spent significantly less time on the waitlist when compared to recipients in the DDLT ≥70y group (102 [49–201] days versus 170 [36–336] days) respectively; p = .004. With the exception of a longer length of stay (LOS) in the LDLT ≥70y group (p ≤ .001), postoperative outcomes were comparable with recipients in the DDLT ≥70y group, including similar graft and patient survival rates at 1‐, 3‐, and 5‐years. When compared to younger recipients of a graft from a living donor, patients in the LDLT ≥70y group had similar post‐transplant functional status, re‐transplant rates and similar causes contributing to graft failure. However, significantly lower graft and patient survival rates were observed.Conclusion: LDLT for recipients aged 70 or greater represents a faster access to transplantation in a safe and feasible manner when compared to similar‐ aged recipients undergoing DDLT.


  • Open Access

    Survival outcomes in adult recipients using pediatric deceased donor liver grafts. A PSM analysis from the OPTN/UNOS liver transplant registry

    by Paola A. Vargas, Mohamad El Moheb, Zachary Henry, Nicolas Intagliata, Feng Su, Matthew Sttots, Curtis Argo, Shawn Pelletier, Jose Oberholzer, Nicolas Goldaracena


  • Early removal of drains and lines after liver transplantation to reduce the length of hospital stay and enhance recovery – A systematic review of the literature and expert panel recommendations

    by Nicolas Goldaracena, Prashant Bhangui, Young‐In Yoon, Paola A. Vargas, Michael Spiro, Dimitri Aristotle Raptis, Yaman Tokat, the ERAS4OLT.ork Working Group

    Background: The timing of removing abdominal drains, central venous catheters (CVC), and urinary catheters (UC) on post liver transplantation (LT) outcomes is not well elucidated.Objectives: To provide international expert panel recommendations and guidelines on time of drain and catheter removal as a part of an ERAS protocol to reduce the length of hospital stay and enhance recovery.Methods: Systematic review following PRISMA guidelines and recommendations using the GRADE approach derived from an international expert panel. Papers considered were those reporting one or more outcomes of interest related to drainage and line removal in the setting of LT. POSPERO Protocol ID: CRD42021238349Results: On analyzing five relevant studies pertaining to drains in patients undergoing LT (four retrospectives and one prospective), the length of hospital and/or ICU stay was similar or shorter, and postoperative morbidity and mortality were lower in those without drains. No studies pertaining specifically to the time of removal of drains, CVC's, or UC's in LT were found. Studies in patients undergoing major abdominal surgery or hepatectomies recommend early removal of CVC and UC to reduce catheter‐associated infections.Conclusions: Based more on expert recommendation, we propose that abdominal drains, if placed during LT, should be removed by postoperative day 5 after LT, based on quantity and fluid characteristics (Quality of Evidence; Low to Moderate | Grade of Recommendation; Strong). Larger studies are needed to more reliably determine indications for early drain and line removal in an ERAS protocol setting.